Zhu et al. found that TTN can promote the proliferation and migration of prostate cancer by inhibiting miR-1271 levels, indicating that TTN may be a prognosis target for prostate cancer (Zhu et al., 2021). The gene discussed is TTN; the disease is prostate cancer.